Molecular markers increase precision of the European Association of Urology non-muscle invasive bladder cancer progression risk groups.
| Author | |
|---|---|
| Abstract | :
The European Association of Urology (EAU) guidelines for non-muscle invasive bladder cancer (NMIBC) recommend risk stratification based on clinicopathological parameters. Our aim was to investigate the added value of biomarkers to improve risk stratification of NMIBC. |
| Year of Publication | :
2018
|
| Journal | :
Clinical cancer research : an official journal of the American Association for Cancer Research
|
| Date Published | :
2018
|
| ISSN Number | :
1078-0432
|
| URL | :
http://clincancerres.aacrjournals.org/cgi/pmidlookup?view=long&pmid=29367430
|
| DOI | :
10.1158/1078-0432.CCR-17-2719
|
| Short Title | :
Clin Cancer Res
|
| Download citation |